Revolutionizing Alzheimer’s Treatment: Anavex’s Blarcamesine Proves Effective in Phase IIb/III Trial – Presented at CTAD Conference 2024

Revolutionizing Alzheimer’s Treatment: Anavex’s Blarcamesine Proves Effective in Phase IIb/III Trial – Presented at CTAD Conference 2024 Data of Blarcamesine confirm upstream SIGMAR1 activation Presented as Late Breaking Oral Communications at Clinical Trials on Alzheimer’s Disease (CTAD) Conference 2024 Oral, once daily blarcamesine meaningfully slowed clinical decline for early Alzheimer’s disease patients with good comparative…

Read More

Join Us in November: NANOBIOTIX Takes the Stage at Exciting Investor Conferences!

Welcome to the Healthcare Innovation Conference Season! Nanobiotix Making Waves at Multiple Conferences PARIS and CAMBRIDGE, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company”), a late-clinical stage biotechnology company pioneering nanoparticle-based approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that…

Read More

Discover Shell Plc’s 2025 Interim Dividend Timetable: A Look into the Future of This Global Corporation

SHELL PLC 2025 INTERIM DIVIDEND TIMETABLE London, October 31, 2024 The Board of Shell plc today announced the intended timetable for the 2025 quarterly interim dividends. 2025 Interim Dividend Timetable Event 4th Quarter 2024 1st Quarter 2025 2nd Quarter 2025 3rd Quarter 2025 Announcement date January 30, 2025 May 2, 2025 July 31, 2025 October…

Read More

Nokia and Viettel Launch High-Capacity Optical Network with Record-Breaking 1.2Tb/s Transmission Speed in Vietnam

Nokia and Viettel collaborate to roll out high-capacity optical network in Vietnam Meeting the increasing demand for 5G and Data Center Interconnect In a recent press release, Nokia announced its partnership with Viettel, Vietnam’s largest service provider, to deploy a high-capacity optical network to support the growing demand for 5G and Data Center Interconnect (DCI),…

Read More